LicianPro

Alice Nettleton

Equity research analyst · UBS

Earnings calls

1

Nov 12, 2026 – Nov 12, 2026

Stocks asked about

1

Questions

1

Firm rating actions

0

on these stocks, from news

Coverage

Companies whose earnings calls Alice Nettleton asked questions on (from Lician's transcripts).

Questions on earnings calls

    • 1:08:30
      “You seem to have benefited from the setbacks with OX40+, which makes sense. There are several atopic derm competitor readouts coming up, including STAT-6 and various bispecifics and trispecifics. If any of these were to have that's not allowed up, they would do it to theЗe as…”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

UBS rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Alice Nettleton. We do not use licensed rating databases.

No rating action by UBS on these stocks in the headlines we store yet.